Amgen to Provide Testimony At FDA Stakeholder Hearing On Biosimilars

THOUSAND OAKS, Calif., May 11, 2012 /PRNewswire/ --Amgen (NASDAQ:AMGN) announced today that Joseph P. Miletich, M.D., Ph.D., senior vice president of Research and Development at Amgen will testify at…
Read the full story: BioSpace.com Featured News